Employees: 01 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: ETICreation date: 1969-01-01 (57 years)Status: ActiveBusiness sector: Activités des sociétés holdingLocation: BOIS-GUILLAUME (76230), Seine-Maritime
CENTRE MEDICO CHIRURGICAL DU CEDRE : revenue, balance sheet and financial ratios
CENTRE MEDICO CHIRURGICAL DU CEDRE is a French company
founded 57 years ago,
specialized in the sector Activités des sociétés holding.
Based in BOIS-GUILLAUME (76230),
this company of category ETI
shows in 2024 a revenue of 3.2 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - CENTRE MEDICO CHIRURGICAL DU CEDRE (SIREN 690501531)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
3 172 617 €
3 024 390 €
2 714 280 €
2 599 120 €
2 573 521 €
2 498 197 €
2 283 573 €
2 118 591 €
N/C
Net income
1 865 046 €
1 819 472 €
1 653 785 €
1 163 384 €
1 197 165 €
1 085 199 €
1 324 113 €
1 729 796 €
1 960 940 €
EBITDA
2 596 171 €
2 341 613 €
2 096 286 €
2 035 245 €
2 178 876 €
1 557 489 €
1 912 315 €
1 889 800 €
-228 092 €
Net margin
58.8%
60.2%
60.9%
44.8%
46.5%
43.4%
58.0%
81.6%
N/C
Revenue and income statement
In 2024, CENTRE MEDICO CHIRURGICAL DU CEDRE achieves revenue of 3.2 M€. Over the period 2017-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +5.9%. Vs 2023: +5%. After deducting consumption (0 €), gross margin stands at 3.2 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 2.6 M€, representing 81.8% of revenue. Positive scissor effect: EBITDA margin improves by +4.4 pts, sign of improved operational efficiency. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 1.9 M€, i.e. 58.8% of revenue. This profit can be retained or distributed to shareholders.
Revenue (2024)
?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production
3 172 617 €
Gross margin (2024)
?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed
3 172 617 €
EBITDA (2024)
?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity
2 596 171 €
EBIT (2024)
?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals
2 153 256 €
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
1 865 046 €
EBITDA margin (2024)
?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability 5-10% : Average < 5% : Low
81.8%
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 14%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 86%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.7 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 72.7% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
14.129%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
86.251%
Cash flow / Revenue (2024)
?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates
72.728%
Repayment capacity (2024)
?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent 3-5 years : Fair > 5 years : Warning
0.664
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution CENTRE MEDICO CHIRURGICAL DU CEDRE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
0.0
19.759
39.091
41.751
33.282
29.174
22.339
18.045
14.129
Financial autonomy
76.773
76.303
70.834
69.719
74.487
74.974
80.606
83.358
86.251
Repayment capacity
0.0
0.758
1.837
3.21
1.652
1.571
0.997
0.805
0.664
Cash flow / Revenue
None%
88.487%
71.919%
41.449%
64.843%
60.937%
76.15%
74.418%
72.728%
Sector positioning
Debt ratio
14.132024
2022
2023
2024
Q1: 0.01
Med: 8.77
Q3: 62.6
Average
In 2024, the debt ratio of CENTRE MEDICO CHIRURGICAL... (14.13) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
86.25%2024
2022
2023
2024
Q1: 15.71%
Med: 62.26%
Q3: 91.3%
Good
In 2024, the financial autonomy of CENTRE MEDICO CHIRURGICAL... (86.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
0.66 years2024
2022
2023
2024
Q1: 0.0 years
Med: 0.09 years
Q3: 3.07 years
Average
In 2024, the repayment capacity of CENTRE MEDICO CHIRURGICAL... (0.66) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 1799.21. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.9x. Danger: operating income does not cover interest charges, unsustainable situation.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
1799.213
Interest coverage (2024)
?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable 1.5-3 : Acceptable < 1.5 : Risk
0.893
Liquidity indicators evolution CENTRE MEDICO CHIRURGICAL DU CEDRE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
2191.617
160.679
589.063
1155.027
2085.621
527.49
1097.354
1382.156
1799.213
Interest coverage
-40.794
3.956
3.832
4.6
2.361
1.722
1.433
1.138
0.893
Sector positioning
Liquidity ratio
1799.212024
2022
2023
2024
Q1: 138.65
Med: 681.09
Q3: 3914.52
Good
In 2024, the liquidity ratio of CENTRE MEDICO CHIRURGICAL... (1799.21) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
0.89x2024
2022
2023
2024
Q1: -74.77x
Med: 0.0x
Q3: 0.0x
Excellent
In 2024, the interest coverage of CENTRE MEDICO CHIRURGICAL... (0.9x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 36 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 43 days. Favorable situation: supplier credit is longer than customer credit by 7 days. Overall, WCR represents 84 days of revenue, i.e. 737 k€ to permanently finance.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
736 586 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
36 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
43 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR in days of revenue (2024)
?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management
84 j
WCR and payment terms evolution CENTRE MEDICO CHIRURGICAL DU CEDRE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
0 €
-137 836 €
127 675 €
56 409 €
38 629 €
5 744 €
280 168 €
202 876 €
736 586 €
Inventory turnover (days)
0
0
0
0
0
0
0
0
0
Customer payment term (days)
0
40
6
7
6
30
35
32
36
Supplier payment term (days)
0
0
152
80
45
5
105
41
43
Positioning of CENTRE MEDICO CHIRURGICAL DU CEDRE in its sector
Comparison with sector Activités des sociétés holding
Valuation estimate
Based on 54 transactions of similar company sales
in 2024,
the value of CENTRE MEDICO CHIRURGICAL DU CEDRE is estimated at
7 382 310 €
(range 1 758 554€ - 14 269 696€).
With an EBITDA of 2 596 171€, the sector multiple of 4.8x is applied.
The price/revenue ratio is 0.59x
(in line with sector norms).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate. Medium reliability: estimate to be confirmed with in-depth analysis.
Estimated enterprise value2024
54 tx
1758k€7382k€14269k€
7 382 310 €Range: 1 758 554€ - 14 269 696€
NAF 5 année 2024
Valuation detail by method
Ajustez les pondérations selon votre analyse
EBITDA Multiple50%
2 596 171 €×4.8x
Estimation12 554 694 €
2 125 202€ - 21 635 402€
Revenue Multiple30%
3 172 617 €×0.59x
Estimation1 867 947 €
1 162 099€ - 2 220 637€
Net Income Multiple20%
1 865 046 €×1.5x
Estimation2 722 896 €
1 736 617€ - 13 929 024€
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 54 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Activités des sociétés holding)
Compare CENTRE MEDICO CHIRURGICAL DU CEDRE with other companies in the same sector:
Frequently asked questions about CENTRE MEDICO CHIRURGICAL DU CEDRE
What is the revenue of CENTRE MEDICO CHIRURGICAL DU CEDRE ?
The revenue of CENTRE MEDICO CHIRURGICAL DU CEDRE in 2024 is 3.2 M€.
Is CENTRE MEDICO CHIRURGICAL DU CEDRE profitable?
Yes, CENTRE MEDICO CHIRURGICAL DU CEDRE generated a net profit of 1.9 M€ in 2024.
Where is the headquarters of CENTRE MEDICO CHIRURGICAL DU CEDRE ?
The headquarters of CENTRE MEDICO CHIRURGICAL DU CEDRE is located in BOIS-GUILLAUME (76230), in the department Seine-Maritime.
Where to find the tax return of CENTRE MEDICO CHIRURGICAL DU CEDRE ?
The tax return of CENTRE MEDICO CHIRURGICAL DU CEDRE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does CENTRE MEDICO CHIRURGICAL DU CEDRE operate?
CENTRE MEDICO CHIRURGICAL DU CEDRE operates in the sector Activités des sociétés holding (NAF code 64.20Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart